The frustrations and costly contradictions of today’s fragmented $2.8 trillion healthcare system are well documented. Despite breathtaking scientific achievements, the US system is marked by inefficiency, waste, a lack of transparency and mixed health outcomes. Put simply, we have not gotten our money’s worth.
But the ground is shifting rapidly, giving way to what we call the “New Health Economy.”Read HRI’s New Health Economy essay.
New entrants in both developed and developing nations are redefining the $9.59 trillion global healthcare market for consumers, providers, payers, and investors. PwC takes a global perspective in how these new entrants are pioneering pathways into virtual healthcare, more affordable and convenient care options, wellness and fitness, and more.
The US health sector’s center of gravity is shifting toward consumers. New players are moving fast to capitalize on the change. These new entrants are poised to shake up the industry, drawing revenue from traditional healthcare organizations while building new markets in the burgeoning New Health Economy. HRI examined these new players, and measured the impact they are having on the industry.Download HRI’s new entrants report
Technology companies are developing a myriad of wearable health devices that can track physical activity, monitor glucose and even sense if the user falls. What do consumers think about wearables? What are the implications for the health industry? PwC’s HRI explores health wearables in its new report, Health wearables: Early Days.Read the report’s executive summary
They are cost conscious and mobile savvy, and do not necessarily stay within the traditional US healthcare system for their care. But, netting the Hispanic consumer and their dollar will not be easy.
For decades, American consumers, policymakers, business leaders and healthcare professionals have experienced repeated, costly, contradictions in our $2.8 trillion fragmented system of care. Put simply, we have not gotten our money’s worth.
Despite breathtaking scientific achievements, the United States has a mixed record of health outcomes. Insurance coverage is expanding but millions still lack basic care. Unnecessary procedures and administrative waste account for more than a third of spending. Productivity gains have been modest as misaligned financial incentives have rewarded inefficiency. And the purchasers of care have no easy way to compare prices or measure the value of services they buy.
But the ground is shifting rapidly, giving way to what we call the “New Health Economy™.”
Technological advances, empowered consumers, disruptive new entrants, and rising demand by an aging population are ushering in a new era in healthcare. While many of those trends have been emerging for some time, never before have they been accompanied by a rapid shift in dollars, triggering major changes in behavior and fundamentally altering the business.
Today healthcare revenue flows from government and employers through third-party payers, insulating consumers from true costs. In the future, purchasers—government, employers and individuals—will direct payment to the entities providing the best value, whether it is a clinical team or a sporting goods company, a nutrition counselor or a website.
In the New Health Economy, “patients” will be “consumers” first, with both the freedom and responsibility that come with making more decisions and spending their own money. These consumers will demand a continuum of well-being, rewarding the trusted advisers that can help achieve that.
In the New Health Economy, the mere collection of data will be replaced with lightning-fast analysis delivered directly to a care team that anticipates problems before they arise. Individuals will be co-creators of their health decisions, spending more of their discretionary dollars on tools that help them live well.
In reality, the revenue opportunity in the New Health Economy is much greater than $2.8 trillion, though many more players will be fighting for their share. In one survey by PwC’s Health Research Institute (HRI), consumers indicated they are willing to spend collectively up to $13.6 billion a year of their own money on medical products such as health-related video games and ratings services. At the same time, HRI estimates the ancillary health market of products and services such as personal trainers, mobile apps and vitamins generates an additional $267 billion.
Care delivery, following the move from inpatient to outpatient services, will inch ever closer to the home via retail businesses, remote monitoring and mobile devices. For incumbent health companies, the emergence of these popular technologies presents a central challenge: to partner or compete?
Successful organizations will squeeze out administrative waste, improve the health of entire communities, reduce costly errors, better manage chronic conditions, understand consumer preferences or develop targeted therapies with proven advantages for a given patient group. Transparency in cost and quality will fuel these developments.
The New Health Economy represents the most significant re-engineering of our health system since employers began covering workers in the 1930s. It goes beyond the recent period of convergence in which business roles blurred. Yes, siloes are coming down as providers, insurers and life sciences companies begin to coalesce around the pressure to demonstrate value. But in the New Health Economy, as the money flows from consumers to new players, today’s siloed disease treatment industry will be replaced by a wide open health marketplace.
Remember the days of having no other option than getting in the car and driving around in search of that must-have item?
Today, consumers have a choice: the easy swipe of a finger and a package at the front door. Mobile devices, sophisticated customer segmentation and demands for convenience and transparency gave birth to new winners in industries such as publishing, entertainment, travel and banking. Money followed the innovators.
Many of the incumbents in those industries took notice too late. Now the shakeup is coming to healthcare and the sector is moving toward the traditional economic principles that govern other industries. Market forces such as robust competition, revenue based on results, and the notion that the customer is king, will play a greater role in the health and wellness space.
Venture capital firms, a leading indicator of economic trends, have diverted their healthcare dollars. Since 2007, investment in medical devices has fallen 40% while software start-ups experienced a 75% increase.
Employers, as major purchasers of care, will continue to drive change. Successful health businesses of the future will tailor strategies to this influential customer. In recent surveys, 44% of employers indicated they are considering offering only high-deductible health plans, while 45% are contemplating moving to a private insurance exchange. Defined contribution plans will likely follow.
Combined with the 51 public exchanges created by the Affordable Care Act, health insurance marketplaces signal a major change in the industry business model from today’s B-to-B environment to a retail-style B-to-C approach.
Next-generation health companies will need different skill sets and investments. Core competencies must evolve to take advantage of technological advances, delivering better clinical outcomes and improving the overall customer experience Organizations must have the courage and agility to fail frequently on their way to success, perhaps via pilots, incubators, crowd sourcing or computer modeling. Expertise in unconventional areas such as behavior change and social media take on greater importance in the New Health Economy.
Many of today’s health companies have begun the journey, refashioning care delivery, tapping into Big Data, taking on more risk and forging unconventional alliances. Consider the number of insurance companies that have invested in major analytics divisions, physician group practices, affordable housing, and healthy food programs.
“We believe in this time of incredible change across the industry that a diversified portfolio matters,” Aetna CEO Mark Bertolini said in describing his strategy of broadening the insurer’s offerings to compete in the changing landscape.
Drug companies are pursuing relationships with universities, patient groups, the makers of remote sensors and computers all with an eye toward faster, cheaper discoveries and proven value for cost-conscious purchasers.
The lines are already blurred. Health systems are securing insurance licenses. A telephone giant advertises its role in treating sick children in India and the Philippines. And drugstores are pushing deeper into care delivery.
Walgreens, for example, sells immunizations, infusion therapy, cholesterol screening and counseling for chronic conditions. The company posts prices publicly and tracks the habits of 74 million customers through a rewards program. It has formed a partnership with a lab business, aligned with nearly 200 well-known health systems, bought an online prescription company and expanded internationally through two major alliances.
These innovators—some incumbents, some newcomers and some hybrids—are sketching out the contours of the New Health Economy.
In the coming months, we will detail our vision for this new era in a series of reports. We’ll calculate the revenue opportunities, illuminate the danger zones and offer practical guidance as businesses navigate a value-based, customer-centric, data-driven world. The first installment, included here, is a look at the new entrants, a cast of retail and telecommunications companies seeking first-mover advantage in the New Health Economy.
New Health Economy is a trademark of PwC.
While the smartphone remains Americans’ device of choice, the tech world is creating a future of wearable devices that promises to entertain consumers, save them money and help them live healthier lives.
Technology companies’ interests in health and wellness have sparked the creation of a myriad of wearable devices, from fitness bands that monitor activity and sleep patterns to flexible patches that can detect body temperature, heart rate, hydration level and more.
These devices produce data that, often enabled with analytics, can be used by consumers to manage their health and by healthcare organizations to improve care and potentially reduce costs through systems such as remote patient monitoring.
Data generated by personal devices can be used by insurers and employers to better manage health, wellness and healthcare costs, and by pharmaceutical and life sciences companies to run more robust clinical trials and capture data to support outcomes-based reimbursement. Many consumers believe wearables can dramatically improve their health.
This potential is fueling venture capital investment in digital health and wearable tech. By mid-2014, digital health startups had raised $2.3 billion, more than they raised in all of 2013. More than $200 million went to digital medical devices such as wearables.
Yet these are the early stages of the technology and product adoption lifecycle. Just one in five American adults owns a wearable, according to a national survey of 1,000 US consumers conducted by PwC in 2014. One in ten uses it every day. At the Rock Health Innovation Summit in August, Genentech CEO Ian Clark called health wearables “a bit trivial right now.”
“I don’t doubt that the wearable piece is going to be a productive business model for people,” Clark told an audience packed with health wearables entrepreneurs. “I just don’t know whether it’s going to bend the curve in terms of health outcomes.”
As wearable technology becomes cheaper and more sophisticated, and data quality improves, these devices and their associated apps will become a part of consumers’ lives and the health ecosystem.
The devices will need to be seamlessly interoperable, more self-sufficient and free from additional steps such as syncing and powering. Companies will need to interpret and use data streaming from these devices. The software side of wearables will be emphasized as much as the hardware. Consumers will place greater value on companies that can help them use data to improve their health.
In the summer of 2014, PwC’s Health Research Institute (HRI) and Consumer Intelligence Series (CIS) sought to better understand American consumers’ attitudes toward wearables through a consumer survey, focus groups with technology thought leaders and interviews with executives from inside and outside of the health industry. HRI’s report, Health wearables: Early days, can be read here. CIS’s wearables report, which covers industries from retail to health to entertainment, can be read here.
Physicians at Dignity Health use Augmedix’s Google Glass program to enter patient information into electronic medical records. Ochsner Health System’s “O Bar” sells a curated selection of wearables and apps that can be “prescribed” by physicians.
And in September, Apple unveiled a smartwatch that can monitor heart rate and activity, one more step toward creating a one-stop-shop for health information for consumers and their healthcare providers. Apple CEO Tim Cook called the Apple Watch “the most personal device we’ve ever created.”
A wearable world is emerging, slowly, helping build a New Health Economy.